• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助治疗时代食管癌、胃癌和结直肠癌的临床TNM分期:文献系统评价

Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature.

作者信息

Shimada Hideaki, Fukagawa Takeo, Haga Yoshio, Okazumi Shin-Ichi, Oba Koji

机构信息

Department of Gastroenterological Surgery Toho University Graduate School of Medicine Tokyo Japan.

Department of Surgery Teikyo University School of Medicine Tokyo Japan.

出版信息

Ann Gastroenterol Surg. 2021 Feb 18;5(4):404-418. doi: 10.1002/ags3.12444. eCollection 2021 Jul.

DOI:10.1002/ags3.12444
PMID:34337289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8316742/
Abstract

AIM

Clinical staging is vital for selecting appropriate candidates and designing neoadjuvant treatment strategies for advanced tumors. The aim of this review was to evaluate diagnostic abilities of clinical TNM staging for gastrointestinal, gastrointestinal cancers.

METHODS

We conducted a systematic review of recent publications to evaluate the accuracy of diagnostic modalities on gastrointestinal cancers. A systematic literature search was performed in PubMed/MEDLINE using the keywords "TNM staging," "T4 staging," "distant metastases," "esophageal cancer," "gastric cancer," and "colorectal cancer," and the search terms used in Cochrane Reviews between January 2005 to July 2020. Articles focusing on preoperative diagnosis of: (a) depth of invasion; (b) lymph node metastases; and (c) distant metastases were selected.

RESULTS

After a full-text search, a final set of 55 studies (17 esophageal cancer studies, 26 gastric cancer studies, and 12 colorectal cancer studies) were used to evaluate the accuracy of clinical TNM staging. Positron emission tomography-computed tomography (PET-CT) and/or magnetic resonance imaging (MRI) were the best modalities to assess distant metastases. Fat and fiber mode of CT may be useful for T4 staging of esophageal cancer, CT was a partially reliable modality for lymph node staging in gastric cancer, and CT combined with MRI was the most reliable modality for liver metastases from colorectal cancer.

CONCLUSION

The most reliable diagnostic modality differed among gastrointestinal cancers depending on the type of cancer. Therefore, we propose diagnostic algorithms for clinical staging for each type of cancer.

摘要

目的

临床分期对于为晚期肿瘤选择合适的候选患者及设计新辅助治疗策略至关重要。本综述的目的是评估临床TNM分期对胃肠道癌的诊断能力。

方法

我们对近期发表的文献进行了系统综述,以评估胃肠道癌诊断方法的准确性。在PubMed/MEDLINE中使用关键词“TNM分期”“T4分期”“远处转移”“食管癌”“胃癌”和“结直肠癌”进行系统文献检索,并检索了2005年1月至2020年7月期间Cochrane综述中使用的检索词。选择关注以下方面术前诊断的文章:(a)浸润深度;(b)淋巴结转移;(c)远处转移。

结果

经过全文检索,最终纳入55项研究(17项食管癌研究、26项胃癌研究和12项结直肠癌研究)来评估临床TNM分期的准确性。正电子发射断层扫描-计算机断层扫描(PET-CT)和/或磁共振成像(MRI)是评估远处转移的最佳方法。CT的脂肪和纤维模式可能有助于食管癌的T4分期,CT是胃癌淋巴结分期的部分可靠方法,CT联合MRI是结直肠癌肝转移最可靠的方法。

结论

不同类型的胃肠道癌中最可靠的诊断方法有所不同。因此,我们提出了每种癌症临床分期的诊断算法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/15b30a762781/AGS3-5-404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/71f6fd03c742/AGS3-5-404-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/ed7d19f89279/AGS3-5-404-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/e1512d99ef56/AGS3-5-404-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/01f0aeed3644/AGS3-5-404-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/2b329bb01516/AGS3-5-404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/15b30a762781/AGS3-5-404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/71f6fd03c742/AGS3-5-404-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/ed7d19f89279/AGS3-5-404-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/e1512d99ef56/AGS3-5-404-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/01f0aeed3644/AGS3-5-404-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/2b329bb01516/AGS3-5-404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3e/8316742/15b30a762781/AGS3-5-404-g001.jpg

相似文献

1
Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature.新辅助治疗时代食管癌、胃癌和结直肠癌的临床TNM分期:文献系统评价
Ann Gastroenterol Surg. 2021 Feb 18;5(4):404-418. doi: 10.1002/ags3.12444. eCollection 2021 Jul.
2
The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature.磁共振成像和正电子发射断层扫描/计算机断层扫描在新诊断前列腺癌的分期中的作用:文献的系统评价。
Eur Urol Oncol. 2021 Jun;4(3):370-395. doi: 10.1016/j.euo.2020.11.002. Epub 2020 Dec 4.
3
FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(FDG-PET-CT)可提高肠型而非弥漫型食管胃腺癌患者术前淋巴结分期的特异性。
Eur J Surg Oncol. 2017 Jan;43(1):196-202. doi: 10.1016/j.ejso.2016.08.020. Epub 2016 Sep 7.
4
5
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.正电子发射断层扫描对食管癌初始分期诊断准确性的增量效应。
Cancer. 2005 Jan 1;103(1):148-56. doi: 10.1002/cncr.20724.
6
F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.F-18 氟脱氧葡萄糖正电子发射断层扫描与计算机断层扫描对高危阴茎癌患者的盆腔和远处分期具有较高的诊断价值。
Eur Urol Focus. 2022 Jan;8(1):98-104. doi: 10.1016/j.euf.2021.02.012. Epub 2021 Mar 6.
7
Hybrid PET/MRI in major cancers: a scoping review.重大癌症的杂交 PET/MRI:范围综述。
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2138-2151. doi: 10.1007/s00259-019-04402-8. Epub 2019 Jul 2.
8
Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.正电子发射断层扫描成像在特定癌症中的临床疗效概述。
Health Technol Assess. 2007 Oct;11(44):iii-iv, xi-267. doi: 10.3310/hta11440.
9
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer.内镜超声检查(EUS)对原发性胃癌术前局部区域分期的诊断准确性。
Cochrane Database Syst Rev. 2015 Feb 6;2015(2):CD009944. doi: 10.1002/14651858.CD009944.pub2.
10
Comparison of Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis.镓标记的前列腺特异性膜抗原配体正电子发射断层扫描/磁共振成像与正电子发射断层扫描/计算机断层扫描用于前列腺癌原发分期的比较:一项系统评价和荟萃分析
Eur Urol Open Sci. 2021 Sep 28;33:61-71. doi: 10.1016/j.euros.2021.09.006. eCollection 2021 Nov.

引用本文的文献

1
The Association between the Number of Retrieved Lymph Nodes and Survival in Gastric Cancer Surgery: A Dutch Population-Based Study.胃癌手术中淋巴结清扫数量与生存的关联:一项基于荷兰人群的研究
Dig Surg. 2025 May 19:1-14. doi: 10.1159/000546436.
2
Initial reduction of the primary tumor or lymph nodes: which is the better prognostic factor in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemotherapy followed by surgery?原发肿瘤或淋巴结的初始缩小:在接受新辅助化疗后进行手术的食管鳞状细胞癌患者中,哪一个是更好的预后因素?
Esophagus. 2025 Apr 28. doi: 10.1007/s10388-025-01128-5.
3
ADAMTS12 serves as a novel prognostic biomarker and promotes proliferation and invasion in gastric cancer.

本文引用的文献

1
Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial.内镜黏膜下剥离术联合辅助放疗治疗 T1a 期食管鳞癌的随机对照研究。
Endoscopy. 2020 Dec;52(12):1066-1074. doi: 10.1055/a-1198-5232. Epub 2020 Jul 15.
2
Advances in the surgical treatment of esophageal cancer since 1965.自1965年以来食管癌外科治疗的进展
Ann Gastroenterol Surg. 2020 Apr 14;4(3):243-249. doi: 10.1002/ags3.12332. eCollection 2020 May.
3
Predicting lymph node metastases with endoscopic resection in cT2N0M0 oesophageal cancer: A systematic review and meta-analysis.
ADAMTS12作为一种新的预后生物标志物,促进胃癌的增殖和侵袭。
Discov Oncol. 2024 Dec 25;15(1):837. doi: 10.1007/s12672-024-01724-4.
4
Evaluating stiffness of gastric wall using laser resonance frequency analysis for gastric cancer.利用激光共振频率分析评估胃癌胃壁硬度
Cancer Sci. 2025 Jan;116(1):143-151. doi: 10.1111/cas.16383. Epub 2024 Oct 28.
5
CT Imaging as a Single Modality for Clinical Staging of Gastric Cancer in Limited Resource Centers: A Retrospective Pilot Study.在资源有限的中心,CT成像作为胃癌临床分期的单一模式:一项回顾性试点研究
J Surg Oncol. 2024 Dec;130(8):1551-1562. doi: 10.1002/jso.27857. Epub 2024 Oct 15.
6
Validation of the cutoff values for the number of metastatic lymph nodes for esophageal cancer staging: a multi-institutional analysis of 655 patients in Japan.食管癌分期中转移性淋巴结数量临界值的验证:日本655例患者的多机构分析
Esophagus. 2024 Oct;21(4):464-471. doi: 10.1007/s10388-024-01084-6. Epub 2024 Aug 24.
7
ASO Author Reflections: The Challenging Journey from cCR to pCR After Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma.ASO作者反思:食管鳞状细胞癌新辅助治疗后从临床完全缓解到病理完全缓解的艰难历程。
Ann Surg Oncol. 2024 Jul;31(7):4317-4320. doi: 10.1245/s10434-024-15035-z. Epub 2024 Feb 16.
8
Impact of MRI on the post-therapeutic diagnosis of T4 esophageal cancer.MRI 对 T4 期食管癌治疗后诊断的影响。
Esophagus. 2023 Oct;20(4):740-748. doi: 10.1007/s10388-023-01010-2. Epub 2023 May 26.
9
Anxiety and depression during 3-year follow-up period in postoperative gastrointestinal cancer patients: prevalence, vertical change, risk factors, and prognostic value.术后胃肠道癌症患者 3 年随访期的焦虑和抑郁:患病率、纵向变化、危险因素和预后价值。
Ir J Med Sci. 2023 Dec;192(6):2621-2629. doi: 10.1007/s11845-023-03318-5. Epub 2023 Mar 2.
10
Construction of survival prediction model for elderly esophageal cancer.老年食管癌生存预测模型的构建
Front Oncol. 2022 Oct 19;12:1008326. doi: 10.3389/fonc.2022.1008326. eCollection 2022.
cT2N0M0期食管癌内镜切除术后淋巴结转移的预测:一项系统评价和荟萃分析。
United European Gastroenterol J. 2020 Feb;8(1):35-43. doi: 10.1177/2050640619879007. Epub 2019 Sep 25.
4
Current status of perioperative chemotherapy for locally advanced gastric cancer and JCOG perspectives.局部进展期胃癌围手术期化疗的现状和 JCOG 的观点。
Jpn J Clin Oncol. 2020 May 5;50(5):528-534. doi: 10.1093/jjco/hyaa005.
5
The enhanced recovery after surgery (ERAS) protocol to promote recovery following esophageal cancer resection.加速康复外科(ERAS)方案促进食管癌切除术后的恢复。
Surg Today. 2020 Apr;50(4):323-334. doi: 10.1007/s00595-020-01956-1. Epub 2020 Feb 11.
6
Essential advances in surgical and adjuvant therapies for colorectal cancer 2018-2019.2018 - 2019年结直肠癌手术及辅助治疗的重要进展
Ann Gastroenterol Surg. 2020 Jan 28;4(1):39-46. doi: 10.1002/ags3.12307. eCollection 2020 Jan.
7
F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer.F-FDG PET/CT 衍生参数可预测食管癌的临床分期和预后。
BMC Med Imaging. 2020 Jan 22;20(1):7. doi: 10.1186/s12880-019-0401-x.
8
Tumor and nodal staging of colon cancer: accuracy of preoperative computed tomography at a Swedish high-volume center.结肠癌的肿瘤和淋巴结分期:瑞典一家大型中心术前计算机断层扫描的准确性。
Acta Radiol Open. 2019 Dec 30;8(12):2058460119888713. doi: 10.1177/2058460119888713. eCollection 2019 Dec.
9
A Phase II study of preoperative chemotherapy with docetaxel, oxaliplatin and S-1 in gastric cancer with extensive lymph node metastasis (JCOG1704).一项关于术前化疗联合多西他赛、奥沙利铂和 S-1 治疗广泛淋巴结转移胃癌的 II 期研究(JCOG1704)。
Future Oncol. 2020 Feb;16(4):31-38. doi: 10.2217/fon-2019-0528. Epub 2020 Jan 10.
10
A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study).一项比较不可治愈的 IV 期结直肠癌中单纯化疗与肿瘤初始切除加化疗的随机对照临床试验:JCOG1007(iPACS 研究)。
Jpn J Clin Oncol. 2020 Jan 24;50(1):89-93. doi: 10.1093/jjco/hyz173.